Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myelodysplastic Syndromes | 8 | 2024 | 1399 | 1.740 |
Why?
|
Primary Myelofibrosis | 1 | 2024 | 209 | 0.780 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2020 | 171 | 0.620 |
Why?
|
Leukemia | 1 | 2023 | 1520 | 0.480 |
Why?
|
Soft Tissue Neoplasms | 1 | 2020 | 1166 | 0.380 |
Why?
|
Sarcoma | 1 | 2020 | 1806 | 0.320 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5716 | 0.270 |
Why?
|
Graft Rejection | 1 | 2018 | 4492 | 0.250 |
Why?
|
Mutation | 6 | 2024 | 30266 | 0.240 |
Why?
|
Prognosis | 7 | 2024 | 30046 | 0.230 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2023 | 3626 | 0.210 |
Why?
|
Anemia, Hemolytic | 1 | 2023 | 164 | 0.190 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9264 | 0.190 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2022 | 93 | 0.180 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 560 | 0.180 |
Why?
|
Cytarabine | 1 | 2020 | 697 | 0.150 |
Why?
|
Stem Cell Transplantation | 2 | 2023 | 1602 | 0.140 |
Why?
|
Myeloproliferative Disorders | 1 | 2022 | 616 | 0.130 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2019 | 647 | 0.120 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2019 | 622 | 0.120 |
Why?
|
Anemia | 1 | 2023 | 1517 | 0.110 |
Why?
|
Humans | 15 | 2024 | 768970 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 65480 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2023 | 81903 | 0.060 |
Why?
|
Core Binding Factors | 1 | 2023 | 29 | 0.060 |
Why?
|
Activin Receptors, Type II | 1 | 2023 | 123 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 13510 | 0.050 |
Why?
|
Risk Assessment | 1 | 2023 | 24333 | 0.050 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2023 | 287 | 0.050 |
Why?
|
Hemolysis | 1 | 2023 | 417 | 0.040 |
Why?
|
Male | 4 | 2024 | 365203 | 0.040 |
Why?
|
Adult | 3 | 2024 | 223851 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59739 | 0.040 |
Why?
|
Middle Aged | 3 | 2024 | 223737 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2022 | 1780 | 0.030 |
Why?
|
Aged | 3 | 2024 | 171786 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3214 | 0.030 |
Why?
|
Child | 1 | 2020 | 80960 | 0.020 |
Why?
|
Sulfonamides | 1 | 2022 | 1981 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21188 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2023 | 3671 | 0.020 |
Why?
|
Female | 3 | 2024 | 397515 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4926 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2019 | 2606 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 13048 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10115 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16731 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12174 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11886 | 0.010 |
Why?
|
Concepts
(49)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_